was supported by a Student Fellowship, Ernst Mach Grant 2021-2023 , the Bernd Rode Award 2024 from ASEA-UNINET network
WEIGHT LOSS GLP-1 weight loss treatments are prescription-based medications that may help support weight management by influencing appetite regulation and metabolism
* Self-scoring by 31 subjects
Never opt for injections from an unlicensed source
CJC-1295 (No DAC) acts as a growth hormone releasing hormone (GHRH analogue) , while Ipamorelin functions as a growth hormone releasing peptide (GHRP)
(This is based on when you started the medication not your current weight) BMI of 35 or higher when you started, OR BMI of 30 or higher AND a serious heart or kidney condition, OR BMI of 27 or higher AND a history of heart attack, stroke, or pre-diabetes 3